Scottish Health and Industry Partnership Group

Overview

The Scottish Health and Industry Partnership Group (SHIP) is an initiative hosted by the Chief Scientist Office (CSO) of the Chief Medical Officer Directorate and the Enterprise and Innovation Division of the Economic Development Directorate. It is aimed towards strengthening Scotland’s innovation activities in health and social care in order to solve real problems and improve quality, efficiency and sustainability of healthcare. SHIP will support Scotland’s economy through activities that strengthen its life sciences sector, attract investment into Scotland, develop large scale innovation projects and support the growth of robust businesses.

The focus of SHIP is on early stage innovation (which includes first wave adoption). This involves the translation of academic and industrial research into clinical/commercial use. SHIP seeks to nurture and grow the infrastructure and culture of innovation, align and foster improved collaboration across key policy areas (including digital, data, economic growth, skills and entrepreneurship), improve the co-ordination of innovation and enterprise agencies and accelerate the pace of adoption of innovative technologies and approaches.

Members

  • David Crossman, Chief Scientist, Health, Scottish Government (Co-chair)
  • Mary McAllan, Director for Economic Development, Scottish Government (Co-chair)
  • Dave Tudor, Co-Chair of Life Sciences Scotland Industry Leadership Group and Managing Director of Medicines Manufacturing Innovation Centre
  • Linda Hanna, Interim CEO, Scottish Enterprise
  • Tom Steele, Chair, NHS Scottish Ambulance Service, Innovation Steering Group
  • Christine McLaughlin, Director of Planning, Scottish Government, Innovation Steering Group
  • Caroline Lamb, CEO of NHS Scotland, and Director General, Health and Social Care, Scottish Government
  • John Connaghan, Chief Operating Officer, Health and Social Care, Scottish Government
  • Peter Mathieson, Lead Member for Health, Universities Scotland
  • Stuart Fancey, Director of Research and Innovation, Scottish Funding Council
  • Jann Gardiner, CEO, NHS Golden Jubilee National Hospital
  • Mary Morgan, CEO, NHS National Services Scotland
  • Matt Whitty, Chief Executive, Accelerated Access Collaborative (AAC)
  • Richard Hebdon, Director of Healthcare and Life Sciences, Innovate UK
  • Julia Dudley, Deputy Director, Innovation, Office for Life Sciences
  • Mary Jones, Deputy Director for Strategy, Investment and Manufacturing, Office for Life Sciences